HGH Fragment 176-191 5mg (Lipolytic Research Peptide)
£58.99
✓ Quality Checked
✓ Third-Party Verified
HGH Fragment 176-191 is a high-purity, synthetically isolated polypeptide representing the distinct C-terminal region of Human Growth Hormone. Engineered specifically to study targeted lipolytic pathways without altering systemic insulin sensitivity. For laboratory and in vitro research use only. Not for human consumption. Not a medicine.
HGH Fragment 176-191 Peptide | Targeted Metabolic Reagent
HGH Fragment 176-191 is a stabilized synthetic analog of the fat-mobilizing domain located at the C-terminus of native Human Growth Hormone. This specific amino acid chain isolates the lipolytic properties of growth hormone while systematically omitting the sequences responsible for growth acceleration and glycemic disruption. It serves as a foundational tool for studying adipose cell lifecycle mechanics and cellular metabolic pathways.
Mechanistic & Cellular Target Channels
Targeted Lipolysis Activation: Mimics native hormone signaling to stimulate beta-3 adrenergic receptors, forcing the breakdown of triglycerides in fat cell models.
Anti-Adipogenesis Vector: Modulates in vitro profiles to suppress the uptake of excess lipids, allowing laboratory evaluation of reduced fatty acid accumulation.
Insulin-Neutral Pathway: Omits the N-terminal sequences of growth hormone, ensuring that blood glucose and insulin resistance markers remain unaffected during laboratory testing models.
Primary Laboratory Research Applications
Adipocyte lifecycle, proliferation, and fat-cell reduction mapping.
Beta-3 adrenergic receptor signaling and metabolic rate modeling.
Lipolytic enzymology and cellular lipid secretion analysis.
Comparative studies regarding peptide-driven fat oxidation without structural tissue growth.
Analytical Verification Specifications
Sequence Domain:
HGH C-Terminus (176-191)
Total Mass Content:
5mg (5,000 mcg)
Purity Benchmark:
≥99.0% (HPLC & Mass Spectrometry Verified)
Molecular Profile:
Modified Synthetic Polypeptide Monomer
Formulation Vector:
Lyophilized Vacuum Solid Cake
⚠️ Preclinical Integrity Notice
All laboratory assets documented within this registry are distributed exclusively for verified laboratory research, analytical control trials, and foundational in vitro testing models. These chemical compounds are strictly not approved for human therapeutic, clinical, veterinary, or diagnostic administration.
